Intervention for Communication Quality of Life in Primary Progressive Aphasia

NCT ID: NCT07219680

Last Updated: 2025-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-03

Study Completion Date

2027-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to determine whether individually tailored speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will be offered to individuals who speak English and/or Spanish. The study will also document how acceptable and beneficial the program is to both patients and their care partners.

The main questions the study aims to answer are:

1. Is the telerehabilitation program feasible and acceptable for people with PPA and their care partners?
2. Do participants with PPA and care partners find treatment beneficial?
3. Which outcome measures are most useful for evaluating changes in communication and quality of life?
4. What patterns of treatment response are seen in participants after completing the program?

The program includes both speech-language therapy and training for care partners.

Participants with PPA will:

1. Complete virtual communication tasks and questionnaires before and after the program
2. Take part in online speech-language therapy sessions
3. Include their care partners in some parts of the program for training and support

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Progressive Aphasia(PPA) Semantic Dementia Logopenic Progressive Aphasia (LPA) Nonfluent Aphasia, Progressive Progressive Aphasia Semantic Variant Primary Progressive Aphasia (svPPA) Semantic Aphasia Logopenic Variant Primary Progressive Aphasia Logopenic Variant of Primary Progressive Aphasia (LPA) Logopenic Progressive Aphasia Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Nonfluent Progressive Aphasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants in Arm 1, the immediate treatment group, will proceed immediately to initial assessments followed by the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRT treatment).

Participants in Arm 2, the waitlist control group, will undergo initial assessment followed by a waiting interval of 10 (Multi-VISTA) or 12 (Multi-LRT) weeks. Following the waiting period, they will be reassessed for cognitive-linguistic and participant-reported outcome measures prior to the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRT treatment).
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Waitlist Control

Individuals in the waitlist-control group will undergo initial assessment followed by a waiting interval of 10 (Multi-VISTA) or 12 (Multi-LRT) weeks. Following the waiting period, they will again complete baseline assessments prior to the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRT treatment).

Group Type OTHER

Multicomponent Lexical Retrieval Training

Intervention Type BEHAVIORAL

In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing names of personally relevant target in multiple communication modalities. Biweekly (approximately one hour each) sessions with a clinician target multimodal communication and the use of strategies to support word retrieval. These skills are also trained via daily independent practice. The participant meets four times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

Multicomponent Video Implemented Script Training in Aphasia

Intervention Type BEHAVIORAL

In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Treatment focuses on production of individually-tailored, personally relevant scripts. The participant completes 30 minutes per day of independent practice, during which they speak in unison with a video model. Biweekly (approximately one hour each) sessions with a clinician target clear and accurate script production, memorization, and conversational usage, as well as multimodal communication. The participant meets 6 times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

Immediate Treatment

Individuals in the immediate treatment group will undergo initial assessment followed immediately by the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRT treatment).

Group Type EXPERIMENTAL

Multicomponent Lexical Retrieval Training

Intervention Type BEHAVIORAL

In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing names of personally relevant target in multiple communication modalities. Biweekly (approximately one hour each) sessions with a clinician target multimodal communication and the use of strategies to support word retrieval. These skills are also trained via daily independent practice. The participant meets four times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

Multicomponent Video Implemented Script Training in Aphasia

Intervention Type BEHAVIORAL

In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Treatment focuses on production of individually-tailored, personally relevant scripts. The participant completes 30 minutes per day of independent practice, during which they speak in unison with a video model. Biweekly (approximately one hour each) sessions with a clinician target clear and accurate script production, memorization, and conversational usage, as well as multimodal communication. The participant meets 6 times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multicomponent Lexical Retrieval Training

In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing names of personally relevant target in multiple communication modalities. Biweekly (approximately one hour each) sessions with a clinician target multimodal communication and the use of strategies to support word retrieval. These skills are also trained via daily independent practice. The participant meets four times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

Intervention Type BEHAVIORAL

Multicomponent Video Implemented Script Training in Aphasia

In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Treatment focuses on production of individually-tailored, personally relevant scripts. The participant completes 30 minutes per day of independent practice, during which they speak in unison with a video model. Biweekly (approximately one hour each) sessions with a clinician target clear and accurate script production, memorization, and conversational usage, as well as multimodal communication. The participant meets 6 times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Multi-LRT Multi-VISTA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A PPA (Gorno-Tempini et al., 2011) or "PPA-plus" (Mesulam et al., 2001) diagnosis
* MMSE score of \> 15 and must be able to produce single monosyllabic words intelligibly.
* Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
* Hearing and vision adequate for participation in teleconference meetings
* Must have a care partner available (someone who will commit to attending teleconference sessions weekly during treatment phases)


* Partners must express willingness to attend and participate in treatment sessions including those targeting dyadic communication goals
* Partners must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
* Partner's hearing and vision should be adequate for participation in teleconference meetings

Exclusion Criteria

* Other central nervous system or medical diagnosis that can account for symptoms
* Psychiatric diagnosis that can account for symptoms
* The participant and/or study partner must have basic experience using a computer.
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maya L Henry, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Texas - Austin

Stephanie M Grasso, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Texas - Austin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas

Austin, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Henry Lab Research Coordinator

Role: CONTACT

512-471-3420

Grasso Lab Research Coordinator

Role: CONTACT

512-232-1440

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carly M Millanski, MS

Role: primary

512-471-3420

Camille Wagner Rodriguez, MS

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Henry ML, Hubbard HI, Grasso SM, Mandelli ML, Wilson SM, Sathishkumar MT, Fridriksson J, Daigle W, Boxer AL, Miller BL, Gorno-Tempini ML. Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain. 2018 Jun 1;141(6):1799-1814. doi: 10.1093/brain/awy101.

Reference Type BACKGROUND
PMID: 29718131 (View on PubMed)

Henry ML, Hubbard HI, Grasso SM, Dial HR, Beeson PM, Miller BL, Gorno-Tempini ML. Treatment for Word Retrieval in Semantic and Logopenic Variants of Primary Progressive Aphasia: Immediate and Long-Term Outcomes. J Speech Lang Hear Res. 2019 Aug 15;62(8):2723-2749. doi: 10.1044/2018_JSLHR-L-18-0144. Epub 2019 Aug 7.

Reference Type BACKGROUND
PMID: 31390290 (View on PubMed)

Dial HR, Hinshelwood HA, Grasso SM, Hubbard HI, Gorno-Tempini ML, Henry ML. Investigating the utility of teletherapy in individuals with primary progressive aphasia. Clin Interv Aging. 2019 Feb 25;14:453-471. doi: 10.2147/CIA.S178878. eCollection 2019.

Reference Type BACKGROUND
PMID: 30880927 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://slhs.utexas.edu/research/aphasia-research-treatment-lab

University of Texas Aphasia Research and Treatment Lab

https://slhs.utexas.edu/research/multilingual-aphasia-and-dementia-research-lab/about-lab

University of Texas Aphasia Multilingual Aphasia and Dementia Research Lab

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R61AG089318

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Augmenting Language Therapy for Aphasia: Levodopa
NCT01429077 COMPLETED PHASE2/PHASE3
Communication Bridge 2
NCT03371706 COMPLETED NA
Aphasia Telerehabilitation
NCT02768922 COMPLETED NA
Communication Bridge Pilot Study
NCT06211374 ACTIVE_NOT_RECRUITING NA
Clinic and Neurophysiology of Aphasia Treatment
NCT05572385 NOT_YET_RECRUITING NA